23 November 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics investigates causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy.
The addition of antitumor necrosis factor-α (TNF-α) agents to the therapeutic armamenta
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors